Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

TCN Talks

TCN Talks artwork

Hospice SSVI Explained: What Your Score Isn’t Telling You | Part One

Nov 4, 202627 minAudio
ShareXLinkedInFacebookWhatsAppEmail

Your hospice SSVI score may leave out the context your leadership team needs most. In “Hospice SSVI Explained: What Your Score Isn’t Telling You | Part One,” Chris Comeaux welcomes HealthPivots’ Lindsay Doak to TCNtalks / Anatomy of Leadership for a closer look at the Service and Spending Variation Index (SSVI). What do hospice utilization and non-hospice spending reveal about care delivery? Where can the measures identify troubling patterns - and where might they raise questions about legitimate providers? Drawing on her experience in home health and hospice analytics, Lindsay explores unexpected spending outside the Medicare hospice benefit, care coordination in skilled nursing facilities, and the risks of letting score management drive clinical decisions. In this episode: • Why avoiding SSVI points does not establish exceptional hospice quality • What non-hospice spending can reveal about gaps in visibility and coordination • Why skin allograft spending raised concerns in the discussion • How utilization measures can help flag concerning patterns • Why live discharge measures and nursing facility demographics deserve context • How leaders can keep patient and family needs central to performance improvement Bring this conversation to your next clinical, quality, or executive team meeting: What does our SSVI score reveal, and what do we still need to investigate? Subscribe for Part Two and more conversations on healthcare leadership, hospice quality, and leading with cause and purpose. Share your perspective in the comments: Which SSVI measure raises the biggest question for your team? Thank you to Netsmart for sponsoring this podcast. Teleios Collaborative Network / https://www.teleioscn.org/tcntalkspodcast

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Transcript

From the show. Tap a time to play from there.

Jeff HaffnerThank you, NetSmart, for sponsoring this podcast.

Melody KingEverything rises and falls on leadership. The ability to lead well is fueled by living your cause and purpose. This podcast will equip you with the tools to do just that. Live and lead with cause and purpose. And now, author of the book The Anatomy of Leadership, and our host, Chris Comeaux.

Chris ComeauxHello and welcome. I'm excited today. We have with us Lindsay Doak, who's the vice president of Data Solutions at NetSport. Lindsay, it's so good to have you.

Lindsay DoakThank you.

Chris ComeauxYep, it's good to have you here. And I'm going to tell our listeners a heads up. I know I sound under the weather. I sound a lot worse than I feel. I'm on the back end of COVID and a lot of people have come down with it. Luckily, I'm kind of three or four or five days kind of removed from turning the corner, but I do know I sound rough. So my apologies to our listeners. I'll try not to let that get in the way of just the amazing things that Lindsay's going to share with us. To our listeners, this is our top news story. This is beginning the month of November. So Top News Stories of October. Cordt Kassner is actually traveling.

Chris ComeauxSo I told him I'm like, look, I got to get Lindsay on the show. He said, proceed without me. And those of you that have been listening throughout the year, you know, we've been using Dr. Byock framework. Top of the quarter. Cordt and I do the Top News Stories together. We'll still have the link in the actual show notes, like we always do, of the top stories that I actually kind of bookmark and also the ones that Cordt points out from a statistical standpoint. But we've been using Dr. Byock framework, and a lot of you know it by now, but just to repeat it, zero tolerance for waste, fraud, and abuse, clinical and programmatic standards, making meaningful data readily available and driving competition based upon quality.

Chris ComeauxSo certainly today's show is gonna check at least three of those about the clinical and programmatic standards, meaningful data readily available, and driving competition based upon quality, because I wanted to speak to someone about SSVI. And so I joked with Lindsay. We've known of each other for a long time. I said I've got the woman, the legend, Lindsay, with us today, and we're gonna be talking about SSVI. Just in case a couple of you don't know Lindsay, let me introduce you. She's the vice president of data and research at Health Pivots, where she leads analytics and research initiatives that help home-based care providers succeed in value-based care, quality improvement, and performance measurement.

Chris ComeauxShe has 20 years of experience in home health and hospice, and she is recognized as a voice in industry data, caps performance and best practices across the healthcare and home care continuum. In fact, Lindsay chairs the National Healthcare at Home Best Practices Study, one of the industry's largest benchmarking efforts with nearly 1,000 participating agencies. And she's previously chaired the National Patient and Family Satisfaction Quality Improvement Project. And she is a frequent speaker. A lot of you know you've encountered her on the State National Association circuit.

Chris ComeauxSo, Lindsay, again, it's good to have you. I warned you I was going to ask you this question. It's usually like the toughest question on the podcast for our guests, but what is your superpower?

Lindsay DoakYeah, you know, you had to think about that one when you get that question, right? Because we don't usually sit back and think about what our superpowers are. But one of the things that my friends have always thought was really unique about me is that you know, I travel a lot. I have to catch airplanes at different times. And I can manifest when I want to wake up and without an alarm, I can wake up at that time. So if I say my flight's at six, I need to wake up at three, I don't even set an alarm and I wake up right at three, which as you and I were talking.

Lindsay DoakThat's amazing. Yeah. Because like then goes into, you know, um just being more intuitive and understanding nuances to conversations and people. And that even goes into some of the data analysis that we do as well.

Chris ComeauxYeah, I love that. In fact, I love we were kind of talking about it in the green room again. It's the one I hate just throwing a curveball if the listener if the uh guest has not thought about it, because that's one usually people will get kind of startled by. And I love as you were kind of thinking out loud and you said, I see things before other people see it. I think that's a superpower as well. I also think that I should go buy a lottery ticket tonight because if you want to share those numbers with me, you know, I will uh we could do that in the green room afterwards.

Chris ComeauxWell, let's talk about SSVI. In fact, I thought who knows what we'll title the show. We never know till we get to the end, but at least kind of thematically, SSVI, a new era of hospice accountability, is kind of at least an interesting way to frame the conversation. So let's start with the basics before we get into the wheeze. But the wheeze is exactly why I wanted you here. What exactly is the SSVI? At least I know it stands for, at least I think it does, service and spending variation index.

Chris ComeauxWhat is CMS attempting to accomplish with this? And why might this be maybe one of the more consequential changes that we've seen in hospice oversight, maybe for quite a while?

Lindsay DoakYeah, absolutely. So you know, because you said you've been in the industry for 30 years, CMS has been trying for a very long time to try to come up with some sort of metrics that analyze hospice in terms of what they consider good performers and what they consider bad performers. We had the special focus program that was heavily flawed because it includes those CAPS scores. Not that those aren't important, but there's a good, what, 40% of hospice organizations that don't even have CAP scores.

Lindsay DoakSo not a good metric if if most of your organizations don't even have scores to report. Um, so then they went back to the drawing table. And what we're seeing, and I think what many people need to be paying attention to is that with the release of SSVI, CMS is warning us of what they are looking for. Um so we as hospices get this per diem payment. You get uh, you know, it's a sort of bundled payment in a way.

Lindsay DoakUm, you get paid, as we learned during COVID, we saw we, you know, we weren't even seeing patients and we are still getting paid. Well, that was, you know, the appropriate thing to do back then. Today, when we don't have a national pandemic, we're seeing hospice organizations that are still doing some of that, not seeing patients and still getting paid. Um, so in the data, what CMS is coming back and saying is we're giving you this money, we're expecting you to use it in an appropriate way. And we see organizations, because keep in mind SSVI is the bottom.

Lindsay DoakIt's not, if you didn't get a point with SSVI, it doesn't mean you're knocking out of the park. It means you're not the worst in the country in those metrics. Um, so they pulled out the bottom for two major categories. Number one, are you seeing your patients? Do you have utilizing your staff, making visits? Um, it's a metric that we have for every hospice in the country. So it's a really appropriate metric. Whether or not you like the points attitude to it, we can talk about that a little later. Um, but it is a good data metric in that there's a good end that we can look at.

Lindsay DoakAnd then the other side to it was we give you this money. We are expecting hospice to then take care of the total cost of care for those patients with that, you know, per diem bundle payment. Are you doing that appropriately or is there excessive spending outside of that payment? So those two things combined, or what CMS is telling us they're gonna be looking at these metrics are gonna, you know, stay here with the final rule, but they're also gonna inform other things like hospice COPs, payment changes.

Lindsay DoakUm, so good to stay attuned to what's going on with this, not just for SSVI, but for what's to come with hospice organizations.

Chris ComeauxWell said. Well, you've spent years looking at data. And so as you examine the patterns underlying SSVI, were you surprised? Like were some of the things you're that Lindsay was like, didn't see that was going to be coming out of the data. And are they undercover, are they uncovering maybe I'll call them fundamental differences and how hospices truly deliver care? Or are they uncovering something maybe more troubling about maybe how the Medicare benefits are being used?

Lindsay DoakYeah, well, I I don't think any of us had SSV on our bingo card last year, right? So no surprise. I mean, we have at Health Pivots the measures that matter. So within the utilization metrics, about 60% of those actually overlap with the measures that matter. So we've been looking at some of those metrics for a good two to three years. Um, so some of them aren't a surprise. I think to me, the biggest surprise is the non-hospice spending. Um, it's it's a number that I wasn't even paying attention to but a year ago.

Lindsay DoakWe've had all these total cost of care studies. We've never actually looked at what happens outside of the hospice benefit with those total cost of care studies. And it's not something that's easily available to anyone. You can't get it and the details unless you have access to the claims data. So as a hospice provider, if you don't even have access to the claims data, you will never know where your non-hospice spending was or where it came from. Um, so that's the one I think that has really turned most hospices on their side. Um, the utilization metrics, you know, some of the surprises that came out of that are just um things like we had the visits for the last two to two to three days of life.

Lindsay DoakNow they're adding two days of life, but changing disciplines. It's it's incredibly confusing to be navigating all these different ways of measuring those last days of life. And so I think those are what are struggling. Um, but for the other utilization metrics, those are things that we've been looking at for a good amount of time.

Chris ComeauxYeah, I'm so glad you brought up the measures that matter. I was blessed to have Bob and Mindy Stewart- Coffee earlier this year. And then we also had um, oh gosh, I'm blanking on her name. I apologize, COVID brain, um, but the CEO of Impassion. And so we had all three of them. And so we did a lot of talking on the measures that matter. So does was Bob kind of like, yeah, I saw this coming, or was he also surprised by the non-hospice spending, Lindsay?

Lindsay DoakI mean, we're all surprised by the non-hospice spending. It was not something that we've even been paying attention to, or even knew the it. I mean, we knew that some of it exists, but none of us knew that it exists to this level. I mean, we did not know that there were billions of dollars of skin allographs occurring. Um the reimbursement for that was crazy. So people obviously went after that because of that reimbursement. Um, and then, you know, some of the metrics for SSVI are a little surprising because they're just not the way we typically calculated them.

Lindsay DoakWe haven't, you know, calculated nursing minutes or weekends. Um, and so adding those into the mix is just more things that a hospice organization has to has to be measuring.

Chris ComeauxWell, you just brought up some good stuff. Um, that was a pretty staggering number you used with the B, billions. And so, and I think there were more than a billion dollars in those skin allographs. Um, so and that was spending associated with hospice patients. Can you just unpack that a little bit more, help folks understand is this actually fraudulent behavior that's actually going on outside of hospice coordination? Um, could legitimate hospice organizations be held accountable for some of these things that they didn't even know was occurring?

Lindsay DoakOh, 100%. That's what's happening. Nobody, nobody I talk to says, oh, I knew that that was occurring, and and we just didn't do anything about it. They just didn't know it was occurring. The skin allographs, I think, have taught us a valuable lesson in that we need better transparency into what's happening to our patients outside of the hospice benefit. And so that's what we're building out in health pivots, just to help people understand. Um, not necessarily you can disagree with the SSVI points, because we know that the SSVI points um aren't fairly distributed when it comes to non-hospice spending, but also feel that the seeing that information is important.

Lindsay DoakIf you're a hospice, you should know what is happening to your patients outside of the hospice benefit, where it's happening, whether or not it's fraud and you should report it, or it's just something that needs better care coordination. You think about patients that are in the active dying process, which are hospice patients, getting somebody coming in and putting all these bandages on them is not something that I would want happening to me. Never mind the the fraud billing that was that was tied to that.

Lindsay DoakAnd so what we're seeing with the skin allographs specifically, going back to the original question, is that a lot of them happen to hospice patients in nursing facilities, skilled nursing facilities. So, you know, between that and the the skilled nursing visits, what we've learned from SSVI, good or bad, is that we need to, you know, take a step back and take a look at what we're doing for care coordination and managing our patients in those specific facilities so that we don't, you know, have that happen to us again with something else down the road.

Chris ComeauxYep, that's well said. You know, I could see a I see the temptation. Um, we've always had that challenge of care coordination within the nursing facilities. Um, yeah, I remember, gosh, I I've been on so many nursing home facility visits with our team, making the case. Nursing homes look at us and say, well, we do we do hospice and palliative care. Well, no, this is where an expert partner, surely more hands-on care would be better for your patients. And then yet I could see many of us throwing our hands up and going, well, we didn't know there were billing for all those patients, all this stuff.

Chris ComeauxAnd I think we have to be careful with that because it kind of proves where you might even remember this, Lindsay. I think we were in like the 11th hour. This is when Don Shoemaker was still over in HPCO, and they were gonna half the reimbursement in the nursing home. They were just gonna say, look, all this stuff, we're just gonna cut it by 50%. And that was gonna be the solution for some of this. And so for us to just throw our hands up and go, well, all this stuff is going on, we didn't know about it. It's almost admitting that we're not really actively involved in the care planning.

Chris ComeauxWe are this weird adjunctive service, which kind of feeds into a lot of the arguments along the way of is good hospice care really needed within nursing facilities? Do you agree, or is that make some comments from your side?

Lindsay DoakYeah, and you know, it I mean, that that was occurring a few years ago, what you were referring to in terms of the reimbursement cuts. It's occurring again. Um, we know that uh they are looking into reducing in some capacity the amount of money we get as hospices for care giving given in skilled nursing facilities. Um, because of this, and you know, we saw that physicians are making visits, we're making visits, aides in the nursing facility are making visits, there's redundancies. And so um, you know, for better or for worse, I think that what this has taught us is that there is going to be some shift into what happens with hospice care and nursing facilities.

Lindsay DoakIt's probably gonna be written into these CLPs and it's probably gonna be passed along to us through some sort of payment adjustment.

Chris ComeauxInteresting. Well, I I don't know if you're a huge fan of Dr. Joan Teno. We're a huge fan of Dr. Teno, and she now has a Substack, which is pretty awesome. And so she's been on a roll. In fact, we're gonna actually have her. She's gonna be the next month top news story of the month podcast because I want to ask her a lot of great questions. Um, but one of her concerns, obviously, is is all around fraudulent are these ghost hospices, and that could they actually receive favorable scores on some of these measures? Because they really have really little, little to no legitimate utilization or outside Medicare spending.

Chris ComeauxMeanwhile, us that are legitimate, um, you know, we're serving more complex patients, and that's usually the mark of a really good hospice program is you have the clinical competencies to care for those patients. So here's kind of the gist of my question. Does SSBI have this risk of maybe confusing some of those statistical outlying poor performing hospices with maybe those that are more clinically sophisticated, could take on more high acuity patients?

Lindsay DoakYeah, there's two fa there's two sides to SSBI, of course. So there's a non-hospice spending and then there's utilization, which we've we've covered. Um when I'm looking at, you know, does this catch fraud, which is the question we're all asking, does it catch fraud? Um, yes and no. Um, I'm happy to finally see some metrics that I do think do catch fraud. So I when we're looking at the data, what we see is that for small agencies, so 25 to 50 or under 25 average daily census, they have higher utilization scores, an average of about three to four.

Lindsay DoakAnd then for those small agencies, they have very low non-hospice spending, which is just basic math. You don't have many people, you don't have a lot of non-hospice spending, right? Days times patient spending is not going to be high. Um, and then for larger hospices or, you know, which is actually the full the majority of hospices that are running organizations, they have higher non-hospice spend and those who have lower utilization scores. So then you would take a look and you would say, oh, does that mean that this high utilization for these small hospices is, yeah, they're fraudulent?

Lindsay DoakNot necessarily. Um, does it mean they're fraudulent? It could. I think that the utilization measures do a a fair job of capturing people who are low performing and those fraudulent hospices because we have metrics. You know, you remember if you're looking at CAP or some of these other outcomes, we don't have metrics. In home health, we have home health value-based purchasing, and home health value-based purchasing is highly flawed because there are organizations out there that have no hospitalizations, no cap, and they get a 5% improvement because they have no metrics.

Lindsay DoakSo that's a very flawed system. Um, for this, they are reporting, and even you get a point, even if you have counts under 11. It's not reported, but you still have a count, you still get a point. And it's based on percentages. So um, you know, if you're a small hospice, which you would consider a ghost hospice, you can add up those percentages pretty quickly if you have a low N as a denominator. So those are the hospices that are actually seeing a lot of those utilization points. And then if you're looking at things like live discharge rates or um nursing minutes, did you do any GIP or CHC?

Lindsay DoakThose sorts of metrics do capture those types of hospices that aren't doing good work. You know, there's other utilization metrics that aren't as good as those as those, but those ones particularly do a great job of capturing what we're trying to do in seeing these fraudulent hospices get penalized.

Chris ComeauxI love your perspective, Lindsay. And it occurred to me when we're in the green room that you're such a great person to be having this conversation with because you've lived home health going from very little measures to ultimately to a true value-based world within their measures. And I bet you probably have seen this on the home health as well, right? As an organ as an industry gets more regulated, the the gravitational pull is to teach to the test, that we're just gonna click those things. So do you think that SSVI might have the unintended consequences where hospices might be incentivized to avoid the more complex patients?

Chris ComeauxThere, therefore they reduce kind of utilization, but then they become overly focused on managing those scores, but yet who gets lost in that process is kind of patient-family needs.

Lindsay DoakYeah. I mean, anytime there's metrics, people are going to work around trying to meet those metrics for good or bad. Um, and so, you know, one of the things that's being talked about right now, which is a tie-in to SSVI because it applies, is this utilization you're underutilizing. Um, if we move to a fee for service model, which we did in home health, if you remember, when we had the therapy, remember we had the therapy, you're gonna see no one having a problem with this utilization because everyone's gonna be utilizing a significant amount to get that reimbursement.

Lindsay DoakAnd the the same is gonna go for these SSVI metrics. You know, you see people already starting to think about how many extra minutes do they need to get out of that bottom 25% because there's that threshold there. Um, and it's not the way that you should be responding to SSVI. You know, if I'm talking to really good hospices that are providing good care, I'm not seeing a lot of utilization points. If you're doing the right thing for the patients and you're balancing that out and you're seeing them on weekends and you're visiting them the appropriate amount of times, you're typically not in any of those jeopardy for that bottom 25% for those utilization points.

Lindsay DoakI mean, there is that the one caveat is that last metric of patients who are discharged live and then come back to the hospice. Now that one's heavily flogged because if you have a very low live discharge rate, because you should, right? We shouldn't be discharging hospice patients, and your discharge rate is 2%. Now you're splitting hairs in terms of the percent that come back to your hospice, and you can easily get 40, 50%. So that's the one metric that I say needs to go away or needs to be rethought.

Lindsay DoakUm but the other ones I do see care being changed. And it's it's unfortunate because that's not what the intent of this was. The intent was just you know, this is what we set out in 1980 to do for hospice. This is what has happened, hospice has shifted a lot, but can we get back to uh making sure that we're seeing our patients?

Chris ComeauxThat's good. You can have already answered the question I was gonna ask you, but let me make sure I ask it out loud. Have you seen are there any hospices you worked with that are actually you're like, this is a good hospice, but yet there was something in the measures that kind of caught them? Is that the is the discharge? Was there any others that you bumped into and like, ooh, this is exposing kind of a flaw in how they're looking at it?

Lindsay DoakYeah, there's I mean, there's good hospices that had some points. That was the biggest flaw because I don't think we should be penalizing agencies for having a low life discharge rate. So I think they need to reconsider that metric. Where I see some, you know, decent hospices struggling is there are areas of the country, for example, Minnesota, that have a high percentage of patients in nursing facilities, skilled nursing facilities. Just these regions, these pockets of the country where that the retirement communities are large in those sections.

Lindsay DoakAnd so if you're a hospice provider working out of Minnesota, that 40% threshold of if you have more than 40% of your hospice days in a nursing facility are going to be a surprise to you because you're probably providing legitimate, legitimate hospice, but your patients happen to be in facilities and now you got that 40%. Um, so that one was a surprise. I think, you know, CMS's intent is that we know that there are hospices chasing nursing facility patients because they have a tendency to have longer lengths of stay and and larger profit.

Lindsay DoakUm, but you know, it does penalize some pockets of the country where that's just the way their demographics are within their organization and their state.

Chris ComeauxYep, we've actually seen that in a couple of programs we work with. In fact, the hospice where I spent a large portion of my career, it always blew me away that we were kind of where the country was gonna be in 2030, that greater than 25% of our population was 65 years or older. Well, if if you were trying to build a community of senior living communities, you're gonna go to that kind of community. And so the number of skilled beds we had in that community was pretty astounding. There's like a thousand skilled beds in a population of 100,000 people. So it was a pretty, but it's because, again, statistically, there's a lot more older population, therefore that program would tend to have a lot more patients within facilities.

Chris ComeauxIt's not they're doing something wrong, it's just actually the demographic of their actual community. Have you ever seen something where like CMS eventually realizes that and they norm that? Or is that just a really tough one because they're kind of painting with such a broad brush?

Lindsay DoakYeah, you know, that's typically, yeah, we've never seen utilization metrics where they've normalized it. You know, typically it's outcome metrics where they've then provided a risk adjustment so that you have sicker patients, you're not expected to have as good of outcomes or hospitalizations. We have yet to see where they're gonna go with these utilization metrics, but um I would expect, you know, with with some of the changes coming down the pipeline, you're gonna see probably less aggressive sales into hospice for these skilled nursing facilities.

Lindsay DoakAnd then they might lax that a bit as those scores um are stabilizing more.

Chris ComeauxWell, well, Lindsay, as we go to this next segment, I have another interesting question. It kind of leads back to Dr. Joan Teno, because she is taking this and turning it every which way, which is what I love about Joan. She's been a hospice medical director, but she's trained as a researcher. So she's like that perfect kind of unicorn that thinks about things kind of separately. So, with that, that's kind of a good lead in. So Dr. Teno raised a fascinating question. CMS is removing hundreds. I've actually heard the number a thousand.

Chris ComeauxNow I've never validated that, but maybe a thousand hospices have just gone away because of CMS's focus on fraud, especially in California. So questionable hospices from Medicare, their entire statistical distribution, underlying SSBI could then change. Could legitimate hospices already just suddenly find themselves classified as outliers, not because their care change, but simply because CMS just removed kind of a huge, fraudulent kind of cohort, if you will, to the comparison group.

Chris ComeauxCould that create a weird statistical distortion?

Jeff HaffnerDon't miss part two of this episode coming this Friday.

Open the transcript file

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. The Hospice Workforce Solution For the Future—with Ron Hetrick | Part Two

    Nov 20, 202632 minAudio

    How many times can you fill the same hospice vacancy before you ask what’s driving people away? The answer might be one task your team dreads doing every shift. In Part Two of The Hospice Workforce Solution For the...

    Credit the people on this episode

  2. The Hospice Workforce Solution for the Future—with Ron Hetrick | Part One

    Nov 18, 202634 minAudio

    The hospice workforce shortage is a leadership challenge that demands action now. Economist Ron Hetrick joins Chris Comeaux to explore how hospice organizations can rethink staffing, develop talent, and prepare for...

    Credit the people on this episode

  3. Why Hospice and Palliative Care Expertise Matters—with Dr. Kristi Newport | Part Two

    Nov 13, 202634 minAudio

    Compassion opens the door - but expertise is what makes the promise of hospice and palliative care real. In Part Two | “Why Hospice and Palliative Care Expertise Matters - with Dr. Kristi Newport,” Chris Comeaux...

    Credit the people on this episode

  4. Why Hospice and Palliative Care Expertise Matters—with Dr. Kristi Newport | Part One

    Nov 11, 202628 minAudio

    What makes hospice and palliative care a medical specialty - and why should healthcare leaders insist on specialized expertise? In Part One of “Why Hospice and Palliative Care Expertise Matters,” Chris Comeaux speaks...

    Credit the people on this episode

  5. Hospice SSVI Explained: What Your Score Isn’t Telling You | Part Two

    Nov 6, 202635 minAudio

    Your hospice SSVI score raises questions. Does your leadership team know what’s driving the answers? In Hospice SSVI Explained: What Your Score Isn’t Telling You | Part Two, Chris Comeaux welcomes back Lindsay Doak to...

    Credit the people on this episode